Iridex reaffirms FY2026 sales guidance at $51M–$53M
Iridex (NASDAQ: IRIX) affirms FY2026 sales outlook of $51.000M–$53.000M versus a $53.227M estimate, keeping guidance unchanged in the stated range.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.